Literature DB >> 11176982

Perifoveal vitreous detachment is the primary pathogenic event in idiopathic macular hole formation.

M W Johnson1, M R Van Newkirk, K A Meyer.   

Abstract

OBJECTIVE: To evaluate the relationship between the posterior vitreous cortex and the posterior retina in eyes with early stages of idiopathic macular hole formation.
METHODS: Twenty-six eyes of 26 consecutive patients with stage 1 or stage 2 idiopathic macular hole underwent complete ophthalmologic examination, contact lens biomicroscopy, and B-scan ultrasonography or vitreoretinal surgery or both. In eyes that were operated on, the posterior cortical vitreous layer was meticulously examined with a silicone-tipped cannula prior to inducing a posterior vitreous detachment.
RESULTS: In 25 (96%) of 26 eyes, one or more examination techniques revealed a shallow, localized detachment of the perifoveal vitreous, typically extending to the level of the vascular arcades. Among these 25 eyes, the posterior hyaloid membrane separation was detectable biomicroscopically in 4 (16%) of 25 eyes, ultrasonographically in 17 (74%) of 23 eyes, and intraoperatively in 23 (100%) of 23 eyes. Persistent vitreous adherence to the foveola was evident in 6 (100%) of 6 eyes with a stage 1 hole and in 12 (92%) of 13 eyes with a stage 2 hole but no operculum.
CONCLUSIONS: These findings suggest that localized perifoveal vitreous detachment (an early stage of age-related posterior vitreous detachment) is the primary pathogenic event in idiopathic macular hole formation. We postulate that detachment of the posterior hyaloid from the pericentral retina leads to foveal dehiscence by exerting anterior traction on the foveola and by localizing into the foveola the dynamic vitreous traction associated with ocular rotations.

Entities:  

Mesh:

Year:  2001        PMID: 11176982

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  31 in total

1.  Infracyanine-assisted internal limiting membrane peeling in macular hole repair: does it make a difference?

Authors:  Kelvin Rivett; Louis Kruger; Sarah Radloff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-29       Impact factor: 3.117

2.  [Transitory reduction of vision without metamorphopsia].

Authors:  R F Degenring; B Kamppeter; G Sauder; J B Jonas
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

3.  Full-thickness macular hole formation associated with pigment epithelial detachment: link or coincidence?

Authors:  Sunildath Cazabon
Journal:  Int Ophthalmol       Date:  2010-06-03       Impact factor: 2.031

4.  Enhanced vitreous imaging optical coherence tomography in primary macular holes.

Authors:  Atsushi Takahashi; Taiji Nagaoka; Akitoshi Yoshida
Journal:  Int Ophthalmol       Date:  2015-09-08       Impact factor: 2.031

5.  Ethnic variation in primary idiopathic macular hole surgery.

Authors:  A Chandra; M Lai; D Mitry; P J Banerjee; H Flayeh; G Negretti; N Kumar; L Wickham
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

6.  Vitreo-retinal interface changes on optical coherence tomography in the fellow eyes of patients with macular hole.

Authors:  Ajit Babu Majji; Jay Kumar Chhablani; Bupesh Bagga
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

7.  Perifoveal vitreous detachment and its macular complications.

Authors:  Mark W Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2005

8.  [The primary objective in macular hole surgery. Ultrastructural features of the vitreomacular interface].

Authors:  R G Schumann; M M Schaumberger; M Rohleder; C Haritoglou; A Kampik; A Gandorfer
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

9.  Is axial length a risk factor for idiopathic macular hole formation?

Authors:  A J Singh; M M K Muqit; W H Woon
Journal:  Int Ophthalmol       Date:  2012-05-08       Impact factor: 2.031

10.  Idiopathic macular holes and direction of vitreomacular traction: structural changes and surgical outcomes.

Authors:  C-Y Tsai; Y-T Hsieh; T-T Lai; C-M Yang
Journal:  Eye (Lond)       Date:  2017-07-21       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.